Grace Therapeutics, Inc. (GRCE)
Free Cash Flow Growth
-78.85%
Quarterly · Period ending:
GRCE Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-78.85%period ending
Latest reported-78.85%period ending
GRCE Quarterly Free Cash Flow YoY % (83.06% → -78.85%)
Year-over-year change
High-resolution chart · PNG
GRCE free cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Free Cash Flow Growth |
|---|---|
| -78.8451% | |
| 42.2262% | |
| 46.0909% | |
| 25.5806% | |
| 49.9166% | |
| -40% | |
| -117.4947% | |
| -100.6152% | |
| 42.3718% | |
| 36.7127% | |
| 49.1671% | |
| 38.5934% | |
| -14.8537% | |
| -6.0095% | |
| 18.8045% | |
| 43.6271% | |
| -29.1678% | |
| -42.2437% | |
| 14.8078% | |
| -8.9383% | |
| 26.2472% | |
| 38.5472% | |
| 26.8718% | |
| 9.1721% | |
| 16.6586% | |
| 55.3235% | |
| 1.2629% | |
| -17.0914% | |
| -52.1027% | |
| -144.0602% | |
| -104.1174% | |
| -203.9896% | |
| -235.6936% | |
| -94.725% | |
| -56.0377% | |
| 32.3546% | |
| -42.8538% | |
| 37.1775% | |
| -125.2167% | |
| 29.4693% | |
| 33.1689% | |
| -1.5999% | |
| -87.3099% | |
| 58.1079% | |
| -127.5346% | |
| -523.4218% | |
| 49.6606% | |
| -7,641.3026% | |
| -45.2429% | |
| 80.0161% | |
| -47.6335% | |
| 103.8893% | |
| 81.4303% | |
| -116.6318% | |
| -48.6112% | |
| -383.6226% | |
| -156.8161% | |
| -158.2554% | |
| -211.6624% | |
| 5.7001% | |
| -110.7231% | |
| -21.0068% | |
| 83.061% |